Immunotech Statements
69
Immunotech Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
—
74.315
25.035
96.193
-96.193
-22.182
-0.144
-118.6
—
-118.11
-0.23
514.58
—
100
—
0
—
0
62.414
0
51.455
0
135.67
0
-135.67
0
-29.577
0
-13.061
0
-178.9
0
—
0
-177.78
0
-0.345
514.58
—
100
—
0
—
0
86.498
0
46.253
0
143.89
0
-143.89
0
2.709
0
-0.72
0
-142.2
0
—
0
-140.33
0
-0.273
514.58
—
100
—
0
—
0
125.69
0
62.101
0
186.98
0
-186.98
0
-20.371
0
0.303
0
-207.01
0
—
0
-206.93
0
-0.402
514.58
—
100
—
0
—
0
100.43
0
42.153
0
147.37
0
-147.37
0
-0.815
0
-0.591
0
-147.6
0
—
0
-147.3
0
-0.286
514.58
—
100
—
0
—
0
177.1
0
41.378
0
223.56
0
-223.56
0
-38.711
0
-0.291
0
-265.06
0
—
0
-265.03
0
-0.544
487.62
—
100
—
0
—
0
90.051
0
27.247
0
121.34
0
-121.34
0
-17.542
0
-0.182
0
-174.07
0
—
0
-174.02
0
-0.435
400
—
100
—
0
—
0
38.591
0
15.51
0
52.224
0
-52.224
0
9.82
0
-0.175
0
-58.521
0
—
0
-58.356
0
-0.146
400
—
100
—
0
—
0
23.953
0
12.25
0
35.683
0
-35.683
0
0.504
0
-7.251
0
-50.533
0
—
0
-50.445
0
-0.126
400